Sanofi SA's Fiscal Year is From January To December - All Figures are in EUR, Billions.
The item "Gross-Profit" stands at 33.06 Billion Euros for the trailing twelve months (TTM) period ending 09/30/2025.
Sanofi SA's third quarter result of 9.76 Billion EUR for the item "Gross Profit" represents an increase of 26.02 percent compared to it's second quarter result.
Also, Sanofi SA's third quarter result of 9.76 Billion EUR for the item "Gross Profit" represents a decrease of -3.12 percent compared to it's third quarter result of last year.
Looking again at the trailing twelve months series (TTM), Sanofi SA's third quarter result of 33.06 Billion EUR for the item "Gross Profit" represents a decrease of -0.94 percent compared to it's second quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 16.26 percent compared to the value the year prior.
The 1 year change in percent is 16.26.
The 3 year change in percent is 6.93.
The 5 year change in percent is 29.59.
The 10 year change in percent is 42.42.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Gross Profit | 905,699,262,464.00 |
![]() | Johnson & Johnson - Gross Profit | 486,508,953,600.00 |
![]() | AbbVie Inc - Gross Profit | 399,570,305,024.00 |
![]() | Roche Holding AG - Gross Profit | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Gross Profit | 280,205,508,085.11 |